Home / Share Price Target / Panaceabio
Panacea Biotec Share Price Target 2024, 2025, 2026 to 2039 With Charts
Panacea Biotec Limited | |||
 | Symbol: PANACEABIO | ||
| Price: ₹394.29 | |||
| Exchange: NSE | |||
| Healthcare -> Biotechnology | |||
Show Table of Contents
Table of Contents
- 1: Panacea Biotec Brief Company Overview
- 1.1: Panacea Biotec Limited: A Healthcare Pioneer with Global Reach
- 1.2: Panacea Biotec Financial Performance
- 1.2.1: Is Panacea Biotec A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Panacea Biotec Share Price Target For 2024
- 2.1.1: Panacea Biotec Share Price Target Table For 2024
- 2.1.2: Summary: Panacea Biotec Share Price Prediction For 2024
- 2.2: Panacea Biotec Share Price Target For 2025
- 2.2.1: Panacea Biotec Share Price Target Table For 2025
- 2.2.2: Summary: Panacea Biotec Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Panacea Biotec Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Panacea Biotec Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Panacea Biotec Past Performance
Panacea Biotec Brief Company Overview
Panacea Biotec Limited: A Healthcare Pioneer with Global Reach
Established in 1984, Panacea Biotec is a renowned biotechnology company headquartered in India. Its core business encompasses research, development, manufacturing, and marketing of pharmaceutical formulations and vaccines.
Panacea Biotec boasts a diverse product portfolio catering to various therapeutic areas, including pain management, diabetes, cardiovascular management, oncology, and gastro-intestinal care. The company also holds a strong position in the vaccine market, offering pneumococcal, dengue, typhoid, and universal flu vaccines.
Panacea Biotec has expanded its global presence, exporting its products to over 36 countries, including the US, Europe, and the Asia-Pacific region. It has collaborations with leading organizations like the Russian Direct Investment Fund and CEPI to develop vaccines against COVID-19 and other viral threats.
The company's commitment to innovation and patient care has earned it a strong reputation in the healthcare industry. Panacea Biotec remains dedicated to addressing unmet medical needs and improving global health.
Panacea Biotec Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 837.9 Crore | Market valuation of Panacea Biotec's shares. |
| Revenue (TTM) | 551.63 Crore | Total revenue generated by Panacea Biotec over the past twelve months. |
| Net Income (TTM) | -11.67 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -2.38% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | -2.12% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +30.6% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio | 2.45 | Company's total debt divided by total shareholder equity. |
| Total Debt | 20.68 Crore | Sum of Panacea Biotec's current & long-term financial obligations. |
| Total Cash | 181.77 Crore | Total amount of liquid funds available to Panacea Biotec. |
| Beta | 0.74 | Beta is less than 1 indicating that the Panacea Biotec's price is less volatile than the market. |
Is Panacea Biotec A Good Buy For Long Term?
Panacea Biotec's recent performance paints a mixed picture. While the company boasts a healthy cash balance of 185 Crore and a modest debt of 20.99 Crore, its recent financial performance is concerning. The company reported a net loss of 1.17 Crore for the last 12 months, with a profit margin of -0.21. Additionally, the stock has experienced negative returns over the past 3, 6, and 12 months. While its 5-year return is slightly positive, its 3-year return is significantly negative. Given this information, Panacea Biotec is not a good buy for long-term investors at this time.
To predict the Panacea Biotec's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Panacea Biotec Share Price Target For 2024
The line chart displays the monthly closing prices of Panacea Biotec with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Panacea Biotec shares in 2024, see the table below.
Panacea Biotec Share Price Target Table For 2024
| Panacea Biotec's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 403.95 (+2.44%) | Price Action: Sep 2006 High |
| 2024 Target 2 | 399.50 (+1.32%) | Price Action: Feb 2007 Low |
| 2024 Target 1 | 394.29 (0%) | Fibonacci Extension Level 199% |
| Current Price | 394.29 | Panacea Biotec's 1 share price as of Tue 19 Nov 2024 |
| Stop Loss 1 | 394.29 (0%) | Fibonacci Retracement Extended 82.6% |
| Stop Loss 2 | 389.70 (-1.17%) | Price Action: 07 Nov 2024 High |
| Stop Loss 3 | 385.00 (-2.36%) | Price Action: Mar 2007 Low |
Summary: Panacea Biotec Share Price Prediction For 2024
In summary, Panacea Biotec has surged by ₹226.39, achieving a notable +134.84% increase from 1st January 2024 to 19 Nov 2024. Our analysis of Panacea Biotec for 2024 predicts an additional rise of 0% to 2.44% by the end of 2024 with three potential targets T1: 394.29, T2: 399.50, T3: 403.95. Stop Loss at SL1: 394.29, SL2: 389.70, SL3: 385.00.
Panacea Biotec has a 52-week high of ₹395.95, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹112.35, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Panacea Biotec.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Panacea Biotec Share Price Target For 2025
The line chart displays the monthly closing prices of Panacea Biotec with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Panacea Biotec shares in 2025, see the table below.
Panacea Biotec Share Price Target Table For 2025
| Panacea Biotec's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 591.01 (+49.89%) | Fibonacci Extension Level 171.8% |
| 2025 Target 2 | 577.83 (+46.54%) | Price Action: Chart |
| 2025 Target 1 | 572.11 (+45.09%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 394.29 | Panacea Biotec's 1 share price as of Tue 19 Nov 2024 |
| Stop Loss 1 | 353.45 (-10.36%) | Price Action: Feb 2008 High |
| Stop Loss 2 | 348.00 (-11.75%) | Price Action: 01 Nov 2024 High |
| Stop Loss 3 | 342.00 (-13.27%) | Price Action: Nov 2007 Low |
Summary: Panacea Biotec Share Price Prediction For 2025
In summary, Panacea Biotec has surged by ₹226.39, achieving a notable +134.84% increase from 1st January 2024 to 19 Nov 2024. Our analysis of Panacea Biotec for 2025 predicts an additional rise of 45.09% to 49.89% by the end of 2025 with three potential targets T1: 572.11, T2: 577.83, T3: 591.01. Stop Loss at SL1: 353.45, SL2: 348.00, SL3: 342.00.
Panacea Biotec has a All-Time high of ₹535.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹112.35, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Panacea Biotec, we have created a specific page for that check here: Panacea Biotec Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Panacea Biotec Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Panacea Biotec share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 20.31% over the next 15 years.
For complete year by year Panacea Biotec long term share price target from 2024, 2025 to 2039 check the below table.
Panacea Biotec Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Panacea Biotec Target | YoY Change % |
|---|---|---|
| 2024 | ₹394.29 | [Current Price] |
| 2024 | ₹388.61 | -1.45% |
| 2025 | ₹716.58 | 84.39% |
| 2026 | ₹1,009.69 | 40.9% |
| 2027 | ₹1,293.99 | 28.15% |
| 2028 | ₹1,729.88 | 33.68% |
| 2029 | ₹2,047.98 | 18.38% |
| 2030 | ₹2,366.98 | 15.57% |
| 2031 | ₹2,601.79 | 9.92% |
| 2032 | ₹2,845.19 | 9.35% |
| 2033 | ₹3,402.58 | 19.59% |
| 2034 | ₹3,707.35 | 8.95% |
| 2035 | ₹4,017.38 | 8.36% |
| 2036 | ₹4,193.89 | 4.39% |
| 2037 | ₹4,396.39 | 4.82% |
| 2038 | ₹5,075.27 | 15.44% |
| 2039 | ₹5,173.54 | 1.93% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Panacea Biotec Past Performance
- In 2000, Panacea Biotec opening price was ₹41.1
- As of Tue 19 Nov 2024 the price stands at ₹394.29.
- This represents a Compound Annual Growth Rate (CAGR) of 9.47%.
- In 24 years, an investment of 10,000 would have become ₹95,934.3.
As we wrap up, we hope you like our study on Panacea Biotec share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Panacea Biotec Share Price History
- Panacea Biotec Price Target Tomorrow
- Panacea Biotec Dividend History
- Panacea Biotec Split History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
